ANL.DEANL.DEXETRA
Loading
EBITDA Over TimeExpanding
Percentile Rank87
3Y CAGR-4.0%
5Y CAGR+11.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-4.0%/yr
vs +24.4%/yr prior
5Y CAGR
+11.8%/yr
Recent deceleration
Acceleration
-28.4pp
Decelerating
Percentile
P87
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$5.54B+10.2%
2025$5.03B+20.7%
2024$4.17B-33.6%
2023$6.27B+2.5%
2022$6.12B+92.5%
2021$3.18B+34.2%
2020$2.37B-9.7%
2019$2.62B-4.8%
2018$2.75B+60.7%
2017$1.71B-